Check out our press release “A Look Back: FSHD Research Advances in 2014,” which summarizes some important advances in our understanding of medical as well as fundamental scientific issues. These include new data on reduced lung capacity in FSHD patients, the first high-throughput drug screen for potential treatments, clues as to why muscles are targeted by the genetic mechanism of the disease, and promising new mouse models. Read it all here.
Posted on: Jan 14, 2015
Leave a Reply